本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cybin Inc

13.61
+0.64004.93%
盘后13.700.0900+0.66%19:53 EDT
成交量:161.56万
成交额:2,172.10万
市值:9.94亿
市盈率:-3.36
高:13.72
开:12.87
低:12.77
收:12.97
52周最高:14.35
52周最低:3.76
股本:7,306.02万
流通股本:5,848.11万
量比:1.11
换手率:2.76%
股息:- -
股息率:- -
每股收益(TTM):-4.0491
每股收益(LYR):-3.8923
净资产收益率:-86.94%
总资产收益率:-44.38%
市净率:4.11
市盈率(LYR):-3.50

数据加载中...

公司资料

公司名字:
Cybin Inc
交易所:
NASDAQ
成立时间:
- -
员工人数:
100
公司地址:
100 King Street West,Suite 5600,Toronto,Ontario,Canada
邮编:
M5X 1C9
电话:
传真:
- -
简介:
Cybin Inc.于2016年10月13日在加拿大安大略省成立。该公司在加拿大、美国、英国和爱尔兰开展业务。该公司专注于通过设计专利药物发现平台,创新药物输送系统,新型配方方法和精神健康障碍治疗方案,将迷幻药发展为治疗学。

董事

名称
职位
Eric Hoskins
Independent Director
Eric So
Director, President
Freda Lewis Hall
Independent Director
Grant Froese
Independent Director
Mark Lawson
Independent Director
Paul Glavine
Chief Growth Officer and Director
Theresa Firestone
Independent Director

股东

名称
职位
Michael Halstead
Chief Executive Officer
Aaron Bartlone
Chief Operating Officer
Greg Cavers
Chief Financial Officer
Amir Inamdar
Chief Medical Officer
Eric So
Director, President
Gabriel Fahel
Chief Legal Officer and Corporate Secretary
George Tziras
Chief Business Officer
Paul Glavine
Chief Growth Officer and Director
Regina Donohue
Chief People Officer